137 related articles for article (PubMed ID: 9010228)
1. Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b.
Wilson CA; Payton MN; Elliott GS; Buaas FW; Cajulis EE; Grosshans D; Ramos L; Reese DM; Slamon DJ; Calzone FJ
Oncogene; 1997 Jan; 14(1):1-16. PubMed ID: 9010228
[TBL] [Abstract][Full Text] [Related]
2. Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells.
Lu M; Conzen SD; Cole CN; Arrick BA
Cancer Res; 1996 Oct; 56(20):4578-81. PubMed ID: 8840964
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
[TBL] [Abstract][Full Text] [Related]
4. Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms.
Lu M; Arrick BA
Oncogene; 2000 Dec; 19(54):6351-60. PubMed ID: 11175350
[TBL] [Abstract][Full Text] [Related]
5. Unclassified variants identified in BRCA1 exon 11: Consequences on splicing.
Anczuków O; Buisson M; Salles MJ; Triboulet S; Longy M; Lidereau R; Sinilnikova OM; Mazoyer S
Genes Chromosomes Cancer; 2008 May; 47(5):418-26. PubMed ID: 18273839
[TBL] [Abstract][Full Text] [Related]
6. BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line.
Aprelikova O; Kuthiala A; Bessho M; Ethier S; Liu ET
Oncogene; 1996 Dec; 13(11):2487-91. PubMed ID: 8957093
[TBL] [Abstract][Full Text] [Related]
7. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.
Chai Y; Chipitsyna G; Cui J; Liao B; Liu S; Aysola K; Yezdani M; Reddy ES; Rao VN
Oncogene; 2001 Mar; 20(11):1357-67. PubMed ID: 11313879
[TBL] [Abstract][Full Text] [Related]
8. Bovine BRCA1 shows classic responses to genotoxic stress but low in vitro transcriptional activation activity.
Krum SA; Womack JE; Lane TF
Oncogene; 2003 Sep; 22(38):6032-44. PubMed ID: 12955082
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of a new BRCA1 variant: A role for BRCT domains in apoptosis.
Gu M; Li H; Shen C; Wu L; Liu W; Miao L; Zheng C
Cancer Lett; 2010 Sep; 295(2):205-13. PubMed ID: 20356671
[TBL] [Abstract][Full Text] [Related]
10. Tissue specific expression of alternative splice forms of human cyclic nucleotide gated channel subunit CNGA3.
Cassar SC; Chen J; Zhang D; Gopalakrishnan M
Mol Vis; 2004 Oct; 10():808-13. PubMed ID: 15534583
[TBL] [Abstract][Full Text] [Related]
11. Expression of Brca1 and splice variant Brca1delta11 RNA levels in mouse mammary gland during normal development and tumorigenesis.
Mixon M; Kittrell F; Medina D
Oncogene; 2000 Nov; 19(46):5237-43. PubMed ID: 11077440
[TBL] [Abstract][Full Text] [Related]
12. The BRCA1 alternative splicing variant Δ14-15 with an in-frame deletion of part of the regulatory serine-containing domain (SCD) impairs the DNA repair capacity in MCF-7 cells.
Sevcik J; Falk M; Kleiblova P; Lhota F; Stefancikova L; Janatova M; Weiterova L; Lukasova E; Kozubek S; Pohlreich P; Kleibl Z
Cell Signal; 2012 May; 24(5):1023-30. PubMed ID: 22245140
[TBL] [Abstract][Full Text] [Related]
13. Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5' end of the BRCA1 gene.
Claes K; Vandesompele J; Poppe B; Dahan K; Coene I; De Paepe A; Messiaen L
Oncogene; 2002 Jun; 21(26):4171-5. PubMed ID: 12037674
[TBL] [Abstract][Full Text] [Related]
14. Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines.
Favy DA; Lafarge S; Rio P; Vissac C; Bignon YJ; Bernard-Gallon D
Biochem Biophys Res Commun; 2000 Jul; 274(1):73-8. PubMed ID: 10903898
[TBL] [Abstract][Full Text] [Related]
15. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments.
Casilli F; Di Rocco ZC; Gad S; Tournier I; Stoppa-Lyonnet D; Frebourg T; Tosi M
Hum Mutat; 2002 Sep; 20(3):218-26. PubMed ID: 12203994
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.
Orban TI; Olah E
Biochem Biophys Res Commun; 2001 Jan; 280(1):32-8. PubMed ID: 11162473
[TBL] [Abstract][Full Text] [Related]
17. Retroviral transduction of splice variant Brca1-Delta11 or mutant Brca1-W1777Stop causes mouse epithelial mammary atypical duct hyperplasia.
Bachelier R; Vincent A; Mathevet P; Magdinier F; Lenoir GM; Frappart L
Virchows Arch; 2002 Mar; 440(3):261-6. PubMed ID: 11889595
[TBL] [Abstract][Full Text] [Related]
18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
19. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
[TBL] [Abstract][Full Text] [Related]
20. Specific deletion of CMF1 nuclear localization domain causes incomplete cell cycle withdrawal and impaired differentiation in avian skeletal myoblasts.
Dees E; Robertson JB; Zhu T; Bader D
Exp Cell Res; 2006 Oct; 312(16):3000-14. PubMed ID: 16904105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
